Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

This study is enrolling participants by invitation only.
Ekomed LLC
Information provided by (Responsible Party):
Galyna Kutsyna, Lisichansk Regional Tuberculosis Dispensary Identifier:
First received: February 2, 2010
Last updated: November 27, 2013
Last verified: November 2013